SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001069530-22-000003
Filing Date
2022-01-06
Accepted
2022-01-06 16:46:04
Documents
12
Period of Report
2022-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20220105x8k.htm   iXBRL 8-K 135616
  Complete submission text file 0001069530-22-000003.txt   258278

Data Files

Seq Description Document Type Size
2 EX-101.SCH sava-20220105.xsd EX-101.SCH 2766
3 EX-101.LAB sava-20220105_lab.xml EX-101.LAB 15376
4 EX-101.PRE sava-20220105_pre.xml EX-101.PRE 10983
6 EXTRACTED XBRL INSTANCE DOCUMENT sava-20220105x8k_htm.xml XML 4773
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 22515341
SIC: 2834 Pharmaceutical Preparations